Research ArticleTUMOR IMMUNOLOGY

NF-κB–dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity

See allHide authors and affiliations

Science Immunology  09 Jul 2021:
Vol. 6, Issue 61, eabg3570
DOI: 10.1126/sciimmunol.abg3570

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology

Navigate This Article